logo
#

Latest news with #LawrenceLoh

CIMB partners Remedi to develop financial solutions for healthcare SMEs
CIMB partners Remedi to develop financial solutions for healthcare SMEs

The Star

time31-07-2025

  • Business
  • The Star

CIMB partners Remedi to develop financial solutions for healthcare SMEs

From left: Gurdip Singh Sidhu, CEO, CIMB Malaysia and CIMB Bank; Lawrence Loh, co-CEO, group commercial and transaction banking, CIMB Group; Dr Khairul Faizi Khalid, managing director, Remedi; and Muhamad Faris Ashraf Md Nasser, chief technology officer; at the MoU signing between CIMB and Remedi Innovations to co-develop digital health and wellness solutions aimed at empowering health tech SMEs KUALA LUMPUR: CIMB Bank Bhd has inked a memorandum of understanding with Remedi Innovations Sdn Bhd to co-develop digital health and wellness solutions for health tech small and medium enterprises (SME). Remedi is a certified provider of Electronic Medical Records (EMR) and digital health solutions, which offers a cloud-based clinic management system that enables healthcare providers to optimise clinic operations and enhance patient care. In a stament, the bank said the partnership was formed as part of CIMB's Digital Labs Innovation Programme, and was designed to embed financial services within the digital platforms used by SMEs. Through this collaboration, CIMB and Remedi will co-develop embedded financial solutions directly within Remedi's digital infrastructure that is tailored to the needs of Remedi's clients – which includes clinics, healthcare providers and pharmaceutical suppliers. With the roll-out, the bank said it plans to on board more digital providers nationwide to accelerate the growth of the health-tech industry. "Healthcare is a high-potential growth sector in Malaysia, and we see significant opportunity to support its digital transformation. "Through this partnership, we aim to help healthcare SMEs streamline operations, improve financial management and ultimately, focus on delivering better care," said CIMB Group commercial and transaction banking co-ceo Lawrence Loh in a statement. Remedi Innovations managing director Dr Khairul Faizi Khalid said by removing the complexity of managing separate financial and operational systems, they are enabling healthcare providers to focus entirely on what they do best – caring for their patients. "This collaboration transforms how healthcare SMEs operate, offering them the convenience of streamlined procurement, payments, and business management tools within the ecosystem they already trust."

CNA938 Rewind - Less waste, but also less recycling in Singapore last year
CNA938 Rewind - Less waste, but also less recycling in Singapore last year

CNA

time23-07-2025

  • Business
  • CNA

CNA938 Rewind - Less waste, but also less recycling in Singapore last year

CNA938 Rewind - Less waste, but also less recycling in Singapore last year Singapore's overall recycling rate dropped to 50 per cent in 2024, its lowest since 2006, according to newly released figures. This marks a decline from the 52 per cent recorded in 2023. Despite the dip in recycling rates, official data show that daily waste generated by homes, retail shops, and industrial firms has decreased compared to a year ago. Lance Alexander and Daniel Martin speak with Professor Lawrence Loh, Director of the Centre for Governance and Sustainability at NUS Business School.

CIMB, Pharmaniaga team up to boost financial flexibility for healthcare SMEs
CIMB, Pharmaniaga team up to boost financial flexibility for healthcare SMEs

New Straits Times

time18-07-2025

  • Business
  • New Straits Times

CIMB, Pharmaniaga team up to boost financial flexibility for healthcare SMEs

KUALA LUMPUR: CIMB Bank Bhd has signed a collaboration agreement with Pharmaniaga Logistics Sdn Bhd, a wholly owned unit of Pharmaniaga Bhd (Pharmaniaga), to enhance supply chain financing and ease payment flexibility for small and medium enterprises (SMEs) in the healthcare sector. The partnership aims to provide greater financial flexibility to clinics, pharmacies and medical buyers across the sector, CIMB said. "Under the collaboration, CIMB and Pharmaniaga will offer enhanced payment flexibility to downstream buyers including private clinics and independent pharmacies through CIMB SME BusinessCard," the bank said in a statement today. Businesses can enjoy up to 50 days of extended credit when purchasing medical supplies using the card and get unlimited 0.5 per cent cash rebate on all Pharmaniaga purchases, offering a valuable incentive to improve cash flow and optimise working capital. Lawrence Loh, CIMB Group co-chief executive officer (group commercial and transaction banking), said that by offering extended credit terms and early settlement incentives, the bank is helping clinics, pharmacies, and medical buyers better manage cash flow and reduce operational strain while enhancing the quality of care they provide. "We aim to further expand our healthcare SME portfolio, driven by strategic collaborations with ecosystem partners and enhanced access to digital, sector-focused financing solutions," he said in the statement. Meanwhile, Pharmaniaga managing director Zulkifli Jafar said this collaboration reflects the pharmaceutical company's strong commitment to supporting its valued business partners with practical financial solutions to manage their supply chains more effectively. "By offering greater payment flexibility and tailored financing options, we aim to empower our partners to grow sustainably while ensuring continuous access to a broad range of pharmaceutical products to serve their clients with confidence," he said.

Singapore firms need better climate reporting as new rules loom
Singapore firms need better climate reporting as new rules loom

Yahoo

time11-03-2025

  • Business
  • Yahoo

Singapore firms need better climate reporting as new rules loom

(Bloomberg) – Singapore's listed companies need to improve climate disclosures as regulators are set to impose new standards starting this year, a new study has found. Fewer than a third of issuers provided all 11 disclosures recommended by the Task Force on Climate-Related Financial Disclosures, according to the study from Singapore Exchange Regulation and the National University of Singapore released Tuesday. It reviewed the latest sustainability reports published through July from 529 companies. One of the biggest holes was around disclosing greenhouse gas releases from clients or suppliers, with only 29% of the firms reporting these so-called Scope 3 emissions, according to the study. 'It's a critical weak link,' Lawrence Loh, director at the university's Centre for Governance and Sustainability said in a briefing, adding that Singapore-listed suppliers will also need the data to adhere to European Union regulations. To better align with global standards, Singapore Exchange's regulatory arm in September asked companies to begin reporting under rules developed by the International Sustainability Standards Board from the 2025 fiscal year. The new rules mean boards must disclose additional climate risks and will require more granular emissions reporting. Given that a majority of Singapore's listed companies are small and medium enterprises with fewer resources, the regulator hasn't yet imposed an overarching timeline for reporting Scope 3 emissions. It plans to ask larger issuers to start disclosing the data from the 2026 fiscal year. Singapore's move to stick with stronger disclosure requirements stands in contrast to the EU, which recently proposed weakening reporting rules amid a corporate backlash. In the US, some states are advancing disclosure proposals while President Donald Trump's administration retreats from federal requirements. More stories like this are available on ©2025 Bloomberg L.P.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store